| 000 | 01122 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517152717.0 | ||
| 264 | 0 | _c20180719 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1557-8992 | ||
| 024 | 7 |
_a10.1089/cap.2016.0200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMunshi, Kaizad | |
| 245 | 0 | 0 |
_aReview of Salient Investigational Drugs for the Treatment of Fragile X Syndrome. _h[electronic resource] |
| 260 |
_bJournal of child and adolescent psychopharmacology _cDec 2017 |
||
| 300 |
_a850-863 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aDrugs, Investigational _xtherapeutic use |
| 650 | 0 | 4 |
_aFragile X Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPawlowski, Katherine | |
| 700 | 1 | _aGonzalez-Heydrich, Joseph | |
| 700 | 1 | _aPicker, Jonathan D | |
| 773 | 0 |
_tJournal of child and adolescent psychopharmacology _gvol. 27 _gno. 10 _gp. 850-863 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cap.2016.0200 _zAvailable from publisher's website |
| 999 |
_c27145047 _d27145047 |
||